SCHEMBL28412554

SCHEMBL28412554

CCOC(=O)COCCOS(=O)(=O)c1ccccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 5/20 0.42
GAA P10253 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
POLB P06746 1/20 0.39
HCRTR2 O43614 1/20 0.38
HSD11B1 P28845 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
ESR1 P03372 1/20 0.36
KMT2A Q03164 1/20 0.36
ESR2 Q92731 1/20 0.36
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28533502 0.95 NLRP3 (0.39) NLRP3GAANPSR1POLBHCRTR2
SCHEMBL28529674 0.91 NLRP3 (0.39) NLRP3GAANPSR1POLBHCRTR2
SCHEMBL28414197 0.88 CYP4F2 (0.40) NLRP3GAANPSR1POLBHCRTR2
SCHEMBL28940101 0.88 POLB (0.42) GAAPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL10487928 0.87 NLRP3 (0.47) NLRP3GAANPSR1POLBHCRTR2
SCHEMBL25199151 0.86 POLB (0.41) GAAPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL23276333 0.85 POLB (0.38) GAANPSR1POLBHSD11B1CYP1A2
SCHEMBL20484021 0.85 CYP1A2 (0.42) GAANPSR1POLBCYP1A2CYP2C9
SCHEMBL23276497 0.84 POLB (0.37) GAANPSR1POLBHSD11B1CYP1A2
SCHEMBL8654494 0.81 KMT2A (0.45) GAANPSR1POLBCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269331-A Androgen receptor modulators and methods of use as proteolytic targeting chimeric ligands 埃萨制药股份有限公司 2022-04-01 CN claimed
CN-111212835-A Compounds and methods for targeted degradation of androgen receptors 阿尔维纳斯运营股份有限公司 2020-05-29 CN claimed
CN-114144401-A Novel quinazoline compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2022-03-04 CN disclosed
CN-111892577-A Compounds and methods for targeted degradation of androgen receptor 阿尔维纳斯运营股份有限公司 2020-11-06 CN disclosed
CN-111212835-A Compounds and methods for targeted degradation of androgen receptors 阿尔维纳斯运营股份有限公司 2020-05-29 CN disclosed